J7502
J7502 – Cyclosporine, oral, 100 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 19 NDCs crosswalked per 100 MG $1.559/unit ASP+6%
📋 J7502 summary
J7502 is a HCPCS Level II J-code used to bill Cyclosporine, oral, 100 mg, billed per 100 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J7502: Cyclosporine Modified(J7502)*, Gengraf, Sandimmune
Code J7502
Billing unit 100 MG Payment limit $1.559/unit NDC-Crosswalk 19
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ7502
DescriptorCyclosporine, oral, 100 mg
Billing unit100 MG
Payment limit / unit$1.559
Est. ASP / unit$1.471 est.
Mapped NDCs19
Data periodQ3 2026
Last updated2026-08-20
💊 About Cyclosporine Injection DRUG GUIDE
Sandimmune injection, given with adrenal corticosteroids (steroid medicines), is used to help prevent the body from rejecting a transplanted kidney, liver, or heart.
It is also used to treat chronic rejection in patients who have already been treated with other immunosuppressive medicines.Sandimmune injection is reserved for patients who are unable to take Sandimmune capsules by mouth.
Because of the risk of a serious allergic reaction (anaphylaxis), the injection form is only used when the oral form is not an option.
Clinical overview from our editorial drug guide for Cyclosporine Injection. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$1.559
Est. ASP / unit
$1.471 est.
Est. after 2% sequester
$1.528
HCPCS dosage
100 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionCyclosporine, oral, 100 mg
CoverageD — Special coverage instructions apply
Pricing indicator57
Type of service1 — Medical care
BETOS-2O1E
ASC payment group—
Action codeN — No maintenance this year
Effective date2000-01-01
Date added2000-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J7502 = 100 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J7502 LEAST EXPENSIVE FIRST
19 NDCs map to J7502. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($1.559/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00093-9018-65 | Cyclosporine Modified 25 mg/1 CAPSULE, LIQUID FILLED | Teva | 30 BLISTER PACK in 1 CARTON (0093-9018-65)... | 25 mg/1 | 8 | $12.47 | $0.317 | ● Active | CMS ASP |
| 00093-9019-65 | Cyclosporine Modified 50 mg/1 CAPSULE, LIQUID FILLED | Teva | 30 BLISTER PACK in 1 CARTON (0093-9019-65)... | 50 mg/1 | 15 | $23.39 | $0.779 | ● Active | CMS ASP |
| 75907-0048-30 | Cyclosporine 100 mg/1 CAPSULE, LIQUID FILLED | Dr. | 30 BLISTER PACK in 1 BOX (75907-048-30) /... | 100 mg/1 | 1 | $1.56 | $1.240 | ● Active | PDAC |
| 00093-9020-65 | Cyclosporine Modified 100 mg/1 CAPSULE, LIQUID FILLED | Teva | 30 BLISTER PACK in 1 CARTON (0093-9020-65)... | 100 mg/1 | 30 | $46.77 | $1.250 | ● Active | CMS + PDAC |
| 23155-0839-30 | CYCLOSPORINE 100 mg/1 CAPSULE, LIQUID FILLED | Heritage | 5 BLISTER PACK in 1 CARTON (23155-839-30)... | 100 mg/1 | 30 | $46.77 | $1.250 | ● Active | CMS + PDAC |
| 60505-4632-03 | CycloSPORINE, Modfied 100 mg/1 CAPSULE, LIQUID FILLED | Apotex | 30 BLISTER PACK in 1 CARTON (60505-4632-3)... | 100 mg/1 | 30 | $46.77 | $1.250 | ● Active | CMS + PDAC |
| 00172-7313-20 | Cyclosporine 100 mg/mL SOLUTION | Teva | 1 BOTTLE in 1 PACKAGE (0172-7313-20) / 50... | 100 mg/mL | 50 | $77.95 | $2.124 | ● Active | CMS + PDAC |
| 60505-0134-00 | Cyclosporine 100 mg/1 CAPSULE, GELATIN COATED | Apotex | 30 CAPSULE, GELATIN COATED in 1 BOTTLE (60... | 100 mg/1 | 30 | $46.77 | $7.291 | ● Active | CMS + PDAC |
| 68084-0921-25 | Cyclosporine 100 mg/1 CAPSULE, GELATIN COATED | American | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084... | 100 mg/1 | 30 | $46.77 | $7.291 | ● Active | CMS ASP |
| 00074-3109-32 | Gengraf Cyclosporine 100 mg/1 CAPSULE | AbbVie | 5 BLISTER PACK in 1 CARTON (0074-3109-32)... | 100 mg/1 | 30 | $46.77 | $7.421 | ● Active | CMS + PDAC |
| 00078-0248-15 | Neoral cyclosporine 100 mg/1 CAPSULE, LIQUID FILLED | Novartis | 30 BLISTER PACK in 1 CARTON (0078-0248-15)... | 100 mg/1 | 30 | $46.77 | $11.773 | ● Active | CMS + PDAC |
| 00074-7269-50 | Gengraf | AbbVie | — | — | 50 | $77.95 | — | — | CMS + PDAC |
| 00078-0110-22 | Sandimmune | Novartis | — | — | 50 | $77.95 | — | — | CMS + PDAC |
| 00078-0241-15 | Sandimmune cyclosporine 100 mg/1 CAPSULE, LIQUID FILLED | Novartis | 30 BLISTER PACK in 1 PACKAGE (0078-0241-15... | 100 mg/1 | 30 | $46.77 | — | ● Active | CMS + PDAC |
| 00078-0274-22 | Neoral cyclosporine 100 mg/mL SOLUTION | Novartis | 1 BOTTLE in 1 CARTON (0078-0274-22) / 50... | 100 mg/mL | 50 | $77.95 | — | ● Active | CMS + PDAC |
| 00078-0241-61 | SANDIMMUNE (INNER PACK, SOFTGEL) 100 MG | Unknown | — | — | 1 | $1.56 | — | — | PDAC |
| 51862-0460-47 | CYCLOSPORINE (USP,SOFT GELATIN) 100 MG | Unknown | — | — | 1 | $1.56 | — | — | PDAC |
| 00093-5742-65 | CYCLOSPORINE (USP,MODIFIED,SOFTGEL) 100 MG | Unknown | — | — | 1 | $1.56 | — | — | PDAC |
| 00185-0933-30 | CYCLOSPORINE (SOFTGEL) 100 MG | Unknown | — | — | 1 | $1.56 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$434.7K
Claims
3,508
Beneficiaries
1,619
Spend / beneficiary
$268.53
Spend / claim
$123.93
Trend by period
Where J7502 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #454 of 824
#449
FIASP PUMPCART* J1811
$460.5K
#450
AMNIOEXCEL BIODEXCEL... Q4137
$457.8K
#451
RENOGRAFT, PER SQ CM... Q4321
$456.2K
#452
ESPEROCT J7204
$454.6K
#453
ALPHANINE SD J7193
$450K
#454
CYCLOSPORINE MODIFIE... J7502
$434.7K
#455
APHEXDA J2277
$433.5K
#456
ALDURAZYME J1931
$424.1K
#457
ONCASPAR J9266
$417.8K
#458
ARISTADA J1944
$412.6K
#459
DEXAMETHASONE SODIUM... J1100
$404.4K
Total claims — #256 of 824
#251
VYALEV J7356
3,614
#252
MEMBRANE GRAFT OR WR... Q4205
3,584
#253
AMCHOPLAST, PER SQ C... Q4316
3,567
#254
PANZYGA J1576
3,549
#255
ALBUKED-5* P9045
3,517
#256
CYCLOSPORINE MODIFIE... J7502
3,508
#257
POLIVY J9309
3,476
#258
LINCOCIN* J2010
3,471
#259
AVEED J3145
3,421
#260
MEROPENEM(J2185) J2185
3,378
#261
IMDELLTRA J9026
3,377
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $434.7K | 1,619 | 3,508 | $268.53 | $123.93 |
| 2025 (Q1-Q4) | $2.22M | 2,343 | 16,836 | $946.87 | $131.77 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$2.28M
Medicare paid
$1.71M
Submitted services
1,143,255
Denial rate
3.9%
Allowed / service
$2.08
Submitted charges
$8.13M
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
📊 What bills under J7502
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
19 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J7502 billing FAQ
What is HCPCS code J7502?
J7502 is a HCPCS Level II J-code used to bill Cyclosporine, oral, 100 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J7502?
One unit of J7502 represents 100 MG. Report the number of units equal to the dose administered divided by 100 MG.
How many units of J7502 should I bill?
Divide the dose administered by the code's unit size (100 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J7502?
The Medicare Part B payment limit is $1.559 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $1.528 per unit. Payment limits are revised quarterly.
Which NDCs bill under J7502?
19 NDCs currently map to J7502 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J7502 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.